WASHINGTON (MedPage Today) -- Head-to-head comparison of transcatheter aortic valve implantation (TAVI) devices favored the second-generation Sapien XT over CoreValve, although the trial was criticized on several fronts. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment